Data Foundry

Drug recalls 2026

Paroxetine Extended-Release Tablets — Class II drug recall D-0877-2026

Ongoing recall by Apotex Corp., reported 2026-10-07, distributed nationwide. Failed dissolution specifications.

Recall numberD-0877-2026
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmApotex Corp., Weston, FL, United States
Recall initiated2026-09-23
Classified2026-09-29
Reported by FDA2026-10-07
DistributedNationwide (US)
Reason classesspecification failure
NDC60505-1316, 60505-1316-03, 60505-1317, 60505-1317-03, 60505-1318, 60505-1318-03, 60505-3673, 60505-3673-03, 60505-3674, 60505-3674-03, 60505-3675, 60505-3675-03
Lot numbersTY9495
Expiration dates2027-05

Product

Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-1318-3

Reason for recall

Failed dissolution specifications.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0877-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-13. Not affiliated with or endorsed by FDA. Not medical or legal advice.